Lv61
2380 积分 2023-11-02 加入
KRAS G12C-associated immunotherapy benefit in NSCLC is substantially mediated by tobacco-induced tumor mutation burden, not allele-specific effects
1个月前
已完结
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
10个月前
已完结
First-Line Immunotherapy for Non-Small-Cell Lung Cancer
1年前
已完结
Harnessing cytokines and chemokines for cancer therapy
1年前
已完结
Hepatoid adenocarcinoma—Clinicopathological features and molecular characteristics
2年前
已完结
MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc–Mediated Cell-Cycle Progression and Proliferation in Lung Cancer
2年前
已完结
皖公网安备34019202002308
